Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind study of topical PeproStat for intraoperative surgical hemostasis
2016-003661-26Phase 2Completed
- Sponsor
- Haemostatix
- Start
- Dec 2016
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of PeproStat in Not applicable and None (2 arms), sponsored by Haemostatix. Primary endpoint: Primary efficacy: mean time to haemostasis at the primary target bleed site. Started Dec 2016; status: completed.
02
Drugs
PeproStat
03
Conditions
Not applicable
Beyond the preview
Go deeper on 2016-003661-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003661-26.